CNS Pharmaceuticals, Inc. (CNSP) vs Skye Bioscience, Inc. (SKYE)
CNS Pharmaceuticals, Inc. and Skye Bioscience, Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Skye Bioscience, Inc. are of similar size ($7.5M and $7.5M). Across the 8 metrics below, CNS Pharmaceuticals, Inc. leads on 6 and Skye Bioscience, Inc. on 2.
Valuation
Profitability
| Metric | CNSP | SKYE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 68.04% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (106.62%) | (233.87%) | (57.72%) |
| Return on assets | (91.64%) | (159.80%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack